Skip to main content

Volume 17 - Issue 1 - January, 2005

Editorial Message
08/01/2008
Richard E. Shaw, PhD, FACC
Dear Readers, This issue of the Journal of Invasive Cardiology commences our 17th year of publication. The growth of the journal over the last year has been phenomenal. I want to thank the staff at HMP Communications for providing the...
Dear Readers, This issue of the Journal of Invasive Cardiology commences our 17th year of publication. The growth of the journal over the last year has been phenomenal. I want to thank the staff at HMP Communications for providing the...
Dear Readers, This issue of the...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
James C. Blankenship, MD; Steven P. Sedlis, MD; Mehrdad Saririan; Sabrina Cugno; Thao Huynh, MD; Louise Pilote, MD, MPH, PhD; Brooke Wilson; Mark J. Eisenberg, MD, MPH
Patients with diabetes mellitus have higher adverse event rates1–4 and a higher risk of restenosis following percutaneous coronary intervention (PCI) compared to non-diabetic patients.5–10 The American College of Cardiology (ACC) and the...
Patients with diabetes mellitus have higher adverse event rates1–4 and a higher risk of restenosis following percutaneous coronary intervention (PCI) compared to non-diabetic patients.5–10 The American College of Cardiology (ACC) and the...
Patients with diabetes mellitus...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Etsuo Tsuchikane, MD, PhD; Kenya Nasu, MD; Satoru Sumitsuji, MD; Takashi Tsuji; Hideo Tamai
The Prostar® XL (Perclose, Redwood City, California) allows the femoral arterial puncture site to be closed percutaneously with two nonabsorbable sutures. The Perclose AcceleRated Ambulation and DischargE (PARADISE) trial1 showed that use of...
The Prostar® XL (Perclose, Redwood City, California) allows the femoral arterial puncture site to be closed percutaneously with two nonabsorbable sutures. The Perclose AcceleRated Ambulation and DischargE (PARADISE) trial1 showed that use of...
The Prostar® XL (Perclose,...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Umesh K. Arora, MD; Meeney Dhir, MD
Thrombin plays a central role in clot formation through platelet activation and fibrin generation at the sites of arterial disruption, such as that caused by angioplasty or plaque rupture.1–3 Thrombin also amplifies its own generation by...
Thrombin plays a central role in clot formation through platelet activation and fibrin generation at the sites of arterial disruption, such as that caused by angioplasty or plaque rupture.1–3 Thrombin also amplifies its own generation by...
Thrombin plays a central role in...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Efthymios N. Deliargyris, MD; Christopher H. Smith; Michael B. Erwin
Case report. A 49-year-old white female presented with recurrent angina. Six months prior, she was successfully treated for a similar anginal syndrome with a 5.0 x 43 Magic Wallstent in the proximal and mid-RCA. Coronary angiography showed a...
Case report. A 49-year-old white female presented with recurrent angina. Six months prior, she was successfully treated for a similar anginal syndrome with a 5.0 x 43 Magic Wallstent in the proximal and mid-RCA. Coronary angiography showed a...
Case report. A 49-year-old white...
08/01/2008
Journal of Invasive Cardiology
Teaching Collection
08/01/2008
Michael J. Lim, MD
Efficiency in the cardiac catheterization lab is tied directly to patient recovery time in many institutions due to the limited recovery space and expenses inherent in the personnel required. This must always be balanced against the quality...
Efficiency in the cardiac catheterization lab is tied directly to patient recovery time in many institutions due to the limited recovery space and expenses inherent in the personnel required. This must always be balanced against the quality...
Efficiency in the cardiac...
08/01/2008
Journal of Invasive Cardiology
Vascular Disease
08/01/2008
Gregory J. Mishkel, MD, FRCPC, FACC, FSCAI; Nilesh J. Goswami, MD
Interventional cardiologists have increasingly translated their coronary skills to the field of peripheral interventions. Patients with cardiovascular disease frequently have associated PVD. This places cardiologists at the vanguard of...
Interventional cardiologists have increasingly translated their coronary skills to the field of peripheral interventions. Patients with cardiovascular disease frequently have associated PVD. This places cardiologists at the vanguard of...
Interventional cardiologists...
08/01/2008
Journal of Invasive Cardiology
Vascular Disease
08/01/2008
Rajiv Maraj; Ronald Gim; Rex J. Winters, MD
Case report. An 86-year-old male with coronary artery disease, congestive heart failure and peripheral arterial occlusive disease presented with claudication, weakness and cramping of his left lower extremity. In March 2003, he had undergone...
Case report. An 86-year-old male with coronary artery disease, congestive heart failure and peripheral arterial occlusive disease presented with claudication, weakness and cramping of his left lower extremity. In March 2003, he had undergone...
Case report. An 86-year-old male...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
James Orlando; Stanley Katz, MD, FACC; Amgad N. Makaryus, MD
It is thought that most coronary artery anomalies are congenital in origin, resulting from varied formation during embryonic development. Although a number of different anomalies may occur, the overall incidence of this abnormality has been...
It is thought that most coronary artery anomalies are congenital in origin, resulting from varied formation during embryonic development. Although a number of different anomalies may occur, the overall incidence of this abnormality has been...
It is thought that most coronary...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
Ellen A. Thompson; Sue Ellen Ferraris; Todd Gress; Victor Ferraris
Spontaneous coronary artery dissection (SCAD) is a rare but potentially lethal event.1,2 It is a separation between the intimal and medial wall of the coronary vessel. The potential result of the dissection is obstruction of the vessel lumen...
Spontaneous coronary artery dissection (SCAD) is a rare but potentially lethal event.1,2 It is a separation between the intimal and medial wall of the coronary vessel. The potential result of the dissection is obstruction of the vessel lumen...
Spontaneous coronary artery...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Chi-Hang Lee, MD, MBBS, MRCP; Huay-Cheem Tan, MBBS, MD; Swee Guan Teo, MBBS, MD; Antono Sutandar, MD; Yean-Teng Lim, MBBS, MD
Although primary percutaneous coronary intervention (PCI) has been proven to be superior to thrombolytic therapy for the treatment of acute ST-elevation myocardial infarction (STEMI),1–3 the latter approach is still widely practiced due to...
Although primary percutaneous coronary intervention (PCI) has been proven to be superior to thrombolytic therapy for the treatment of acute ST-elevation myocardial infarction (STEMI),1–3 the latter approach is still widely practiced due to...
Although primary percutaneous...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Ron Waksman, MD; William O. Suddath, MD; Lowell F. Satler, MD; Seung-Woon Rha, MD, PhD; Kenneth M. Kent, MD, PhD; Augusto D. Pichard, MD, FACC, FSCAI; Pramod K. Kuchulakanti, MD; Edouard Cheneau, MD; Robert Lew, MD; Rajbabu Pakala, MD, PhD; Emmanouil I. Kapetanakis; Elizabeth Haile; Paul Corso
Clopidogrel is an oral antiplatelet agent which selectively and irreversibly inhibits the platelet adenosine 5'-diphosphate (ADP) receptor. Antiplatelet effect is synergistic when administered with aspirin. Dual antiplatelet therapy with...
Clopidogrel is an oral antiplatelet agent which selectively and irreversibly inhibits the platelet adenosine 5'-diphosphate (ADP) receptor. Antiplatelet effect is synergistic when administered with aspirin. Dual antiplatelet therapy with...
Clopidogrel is an oral...
08/01/2008
Journal of Invasive Cardiology
Commentary
08/01/2008
Steven L. Goldberg, MD
Despite several studies showing an advantage of early treatment with clopidogrel in the patient presenting with acute coronary syndrome, or prior to percutaneous coronary intervention (PCI),1–6 this treatment is frequently not given early...
Despite several studies showing an advantage of early treatment with clopidogrel in the patient presenting with acute coronary syndrome, or prior to percutaneous coronary intervention (PCI),1–6 this treatment is frequently not given early...
Despite several studies showing...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Patrick W. Serruys, MD, PhD; Sjoerd H. Hofma, MD; Eugene P. McFadden, MB, MD; Georgios Sianos, MD, PhD; Pieter C. Smits, MD, PhD; Willem J. van der Giessen, MD, PhD; Pim J. de Feyter, MD, PhD; Ron T. van Domburg, PhD; Jiro Aoki, MD; Gaston A. Alfredo Rodriguez-Granillo, MD; Andrew T.L. Ong, MD, MBBS, PhD; Maniyal Vijayakumar; Angela Hoye, MB, MRCP, MD, MBChB; Pedro A. Lemos, MD
Ostial atherosclerotic lesions constitute a distinct substrate for percutaneous interventions, as they differ from the other lesion sites in management strategies and in clinical outcomes. Since the lesions are more likely fibrotic and...
Ostial atherosclerotic lesions constitute a distinct substrate for percutaneous interventions, as they differ from the other lesion sites in management strategies and in clinical outcomes. Since the lesions are more likely fibrotic and...
Ostial atherosclerotic lesions...
08/01/2008
Journal of Invasive Cardiology
Commentary
08/01/2008
Shahid Aziz, BSc, MD, MRCP, MBChB; David R. Ramsdale, FRCP, MD, BSc, MBChB
This prospective observational study examines the use of sirolimus-eluting stents (SES) for the treatment of atherosclerotic ostial lesions.1 Ostial lesions that involve the junction of the aorta and the origin of the right coronary artery,...
This prospective observational study examines the use of sirolimus-eluting stents (SES) for the treatment of atherosclerotic ostial lesions.1 Ostial lesions that involve the junction of the aorta and the origin of the right coronary artery,...
This prospective observational...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Riya Ogura; Hitoshi Miyajima; Tatsuro Ogata; Kenichiro Yuba; Shinobu Hosokawa; Yoshikazu Ohara, MD; Koichi Kishi, MD; Yoshikazu Hiasa, MD; Takefumi Takahashi, MD; Shinobu Hosokawa, MD; Naoki Suzuki, MD; Hiroshi Miyamoto, MD; Ryuji Otani, MD; Takeshi Tomokane; Kouji Yamaguchi
Coronary interventions of non-aorto ostial stenoses remain a challenging task with a high rate of procedural complications and restenosis. The lack of efficacy of conventional balloon angioplasty in non-aorto ostial coronary intervention has...
Coronary interventions of non-aorto ostial stenoses remain a challenging task with a high rate of procedural complications and restenosis. The lack of efficacy of conventional balloon angioplasty in non-aorto ostial coronary intervention has...
Coronary interventions of...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
Varinder Singh, MD; Salvatore Rametta, MD; Gregory Valania, MD; Zlata Platzman; James R. Wilentz, MD; Michael S. Lee, MD, DPM, FACFAS, FACC, FSCAI; Raj R. Makkar, MD
Percutaneous coronary intervention (PCI) on thrombus-containing lesions represents a clinical challenge to the interventional cardiologist, since thrombus has been identified as a predictor of adverse outcome.1,2 While attempting to...
Percutaneous coronary intervention (PCI) on thrombus-containing lesions represents a clinical challenge to the interventional cardiologist, since thrombus has been identified as a predictor of adverse outcome.1,2 While attempting to...
Percutaneous coronary...
08/01/2008
Journal of Invasive Cardiology
Commentary
08/01/2008
Michael J. Lim, MD
Percutaneous treatment of patients with a visible intracoronary thrombus has been recognized as a procedure associated with higher risk for complications. For patients with intracoronary thrombus in the stent era, the potentially worse...
Percutaneous treatment of patients with a visible intracoronary thrombus has been recognized as a procedure associated with higher risk for complications. For patients with intracoronary thrombus in the stent era, the potentially worse...
Percutaneous treatment of...
08/01/2008
Journal of Invasive Cardiology